A panel of multivalent nanobodies broadly neutralizing Omicron subvariants and recombinant
Description
The emerging Omicron subvariants have a remarkable ability to spread and escape nearly all current monoclonal antibody (mAb) treatments. Although the virulence of SARS-CoV-2 has now diminished, it remains a significant threat to public health due to
